Rhythm Biosciences Limited (ASX:RHY)
0.0880
-0.0030 (-3.30%)
Sep 2, 2025, 12:46 PM AEST
Rhythm Biosciences Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2017 - 2020 |
Cash & Equivalents | 1.4 | 0.71 | 4.12 | 7.55 | 2.23 | Upgrade |
Short-Term Investments | 0.09 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade |
Cash & Short-Term Investments | 1.48 | 0.75 | 4.17 | 7.6 | 2.27 | Upgrade |
Cash Growth | 96.45% | -81.90% | -45.11% | 234.10% | 23.36% | Upgrade |
Accounts Receivable | 0.06 | - | - | - | - | Upgrade |
Other Receivables | - | 0.04 | 0.07 | 0.08 | 0.16 | Upgrade |
Receivables | 0.06 | 0.04 | 0.07 | 0.08 | 0.16 | Upgrade |
Inventory | 0.07 | - | 2.77 | - | - | Upgrade |
Prepaid Expenses | 0.19 | 0.09 | 0.12 | 0.09 | 0.06 | Upgrade |
Total Current Assets | 1.81 | 0.89 | 7.12 | 7.77 | 2.49 | Upgrade |
Property, Plant & Equipment | 0.17 | 0.28 | 0.19 | 0.24 | 0.11 | Upgrade |
Other Intangible Assets | 0.85 | 0.35 | 0.39 | 0.43 | 0.46 | Upgrade |
Total Assets | 2.83 | 1.52 | 7.7 | 8.44 | 3.07 | Upgrade |
Accounts Payable | 0.87 | 0.21 | 1.33 | 0.28 | 0.6 | Upgrade |
Accrued Expenses | - | 0.27 | 0.35 | 0.57 | 0.74 | Upgrade |
Current Portion of Long-Term Debt | 1 | - | - | - | - | Upgrade |
Current Portion of Leases | 0.11 | 0.08 | 0.08 | 0.09 | - | Upgrade |
Other Current Liabilities | 0.18 | - | - | - | - | Upgrade |
Total Current Liabilities | 2.16 | 0.56 | 1.77 | 0.93 | 1.34 | Upgrade |
Long-Term Leases | 0 | 0.09 | - | 0.08 | - | Upgrade |
Other Long-Term Liabilities | 0.01 | 0 | 0.06 | 0.05 | 0.02 | Upgrade |
Total Liabilities | 2.17 | 0.65 | 1.82 | 1.07 | 1.36 | Upgrade |
Common Stock | 37.75 | 34.45 | 31.55 | 27.83 | 15.98 | Upgrade |
Retained Earnings | -42.5 | -38.67 | -31.82 | -23.6 | -14.81 | Upgrade |
Comprehensive Income & Other | 5.41 | 5.09 | 6.14 | 3.14 | 0.53 | Upgrade |
Shareholders' Equity | 0.66 | 0.87 | 5.87 | 7.37 | 1.71 | Upgrade |
Total Liabilities & Equity | 2.83 | 1.52 | 7.7 | 8.44 | 3.07 | Upgrade |
Total Debt | 1.11 | 0.16 | 0.08 | 0.17 | - | Upgrade |
Net Cash (Debt) | 0.37 | 0.59 | 4.08 | 7.43 | 2.27 | Upgrade |
Net Cash Growth | -36.52% | -85.54% | -44.99% | 226.62% | 26.26% | Upgrade |
Net Cash Per Share | 0.00 | 0.00 | 0.02 | 0.04 | 0.01 | Upgrade |
Filing Date Shares Outstanding | 283.17 | 248.6 | 220.92 | 214.18 | 202.25 | Upgrade |
Total Common Shares Outstanding | 283.17 | 248.6 | 219.79 | 214.18 | 202.17 | Upgrade |
Working Capital | -0.35 | 0.32 | 5.35 | 6.84 | 1.15 | Upgrade |
Book Value Per Share | 0.00 | 0.00 | 0.03 | 0.03 | 0.01 | Upgrade |
Tangible Book Value | -0.19 | 0.51 | 5.48 | 6.95 | 1.24 | Upgrade |
Tangible Book Value Per Share | -0.00 | 0.00 | 0.02 | 0.03 | 0.01 | Upgrade |
Machinery | - | 0.46 | 0.37 | 0.28 | 0.26 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.